Pharmacy Benefit Managers · Pharmacy Benefit Manager · Regulatory action
OptumRx (UnitedHealth)
Headline
OptumRx is the third defendant in the FTC insulin case, and its case was withdrawn from adjudication so the Commission could consider a proposed consent agreement - meaning all three of the largest PBMs in the country…
Not independently verified. Verification status: Unverified - heuristic first draft. Publish state: draft unverified.
OptumRx is the third defendant in the FTC insulin case, and its case was withdrawn from adjudication so the Commission could consider a proposed consent agreement - meaning all three of the largest PBMs in the country moved to resolve the same allegation rather than litigate it. The structural point worth carrying out of this row is vertical integration: OptumRx, UnitedHealthcare and the naviHealth algorithm documented in the Life-Health-Dental tab all sit inside UnitedHealth Group, so the same corporate parent sets your insurance coverage, decides your post-hospital rehabilitation, and prices your prescriptions. A patient experiencing all three as separate frustrations is dealing with one company.
- Severity
- Evidence tierUnassigned
- Claims confirmed
- Last verified2026-08-04
Primary source. None recorded — Unverified - heuristic first draft.
Terms
Arbitration
Not independently confirmed this pass — standard binding arbitration + class action waiver expected for individual member disputes, separate from the government-brought FTC action.
Data sharing
SAME FTC INSULIN-PRICING CASE as Caremark/Express Scripts (see those rows) — OptumRx agreed to a PROPOSED settlement in June 2026 (the last of the three PBMs to reach a deal), following the template set by Express Scripts' earlier settlement; specific final terms not yet independently confirmed this pass. OptumRx is owned by UnitedHealth Group — the SAME parent company as Change Healthcare, whose 2024 ransomware breach is separately documented in the CareFirst BlueCross BlueShield row (Insurance tab) of this tracker, where CareFirst itself sued Change Healthcare over that incident.
Fees and billing
The $7 billion projected savings figure in the Express Scripts row is specific to the Express Scripts settlement; no terms or dollar figures had been disclosed for OptumRx's proposed settlement as of June 2026.
Contacts
Privacy contact. Not recorded.
Legal notice. Not verified this pass. If publicly traded: SEC Form 10-K cover page gives the official corporate address; the Secretary of State business-entity search in the state of incorporation gives the registered agent, which must accept service. If private: the state registered agent is usually the only reliable route.
Mailing address. Not recorded.
Evidence
No claims have been itemized for this row yet.
No sources are on file for this row yet.
Source vault
Link status: Candidate - not yet fetched
| Document | Last fetch | |
|---|---|---|
| Privacy policy optumrx.com/legal/privacy-policy | Not fetched yet | NO (HTML only) |
| Terms of service optumrx.com/legal/terms-of-use | Not fetched yet | NO (HTML only) |
| Website No URL recorded | Not fetched yet | — |
| Primary source No URL recorded Verification: Unverified - heuristic first draft | Not fetched yet | — |
Enforcement
No enforcement actions are linked to this row.
State statute
No HQ state on file, so no state statute applies by headquarters.